| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |